/

Clene

Developing nanotechnology-based drugs for neurodegenerative diseases.

BiotechnologyPharmaceuticals clene.com ↗

Company facts

Founded: 2013
Employees: 80
Headquarters: United States
Type: Public
Listed: NASDAQ: CLNN
Subsidiaries: Clene Nanomedicine, Inc.